Search - tctmd.com

Displaying 581 - 600 of 744

Sort: Relevancy | Date

News Conference News ACC 2014

Global SYMPLICITY Registry Still Shows Positive Results for Renal Denervation

Yael L. Maxwell

March 30, 2014

News Daily News

High Sensitivity Troponin T Assay Shows Strong Prognostic Ability in STEMI Patients

L.A. McKeown

March 20, 2014

News Daily News

CoreValve Reduces Mortality at 1 Year in Patients at Extreme Surgical Risk

March 20, 2014

News Daily News

CoreValve Reduce la Mortalidad al cabo de 1 Año en Pacientes de Riesgo Quirúrgico Extremo

March 20, 2014

News Industry News

Abbott Completes Enrollment of Absorb™ Randomized Clinical Trials in the United States, Japan and China

March 10, 2014

News Daily News

Una Prueba de Reactividad Coronaria Resulta Prometedora en Pacientes con Arterias No Obstruidas

Yael L. Maxwell

March 06, 2014

News Daily News

Transcatheter Device Matches Surgery for Closure of Ventricular Septal Defects

February 06, 2014

News Daily News

TAVR-Linked Conduction Abnormality Worsens Functional Status, but Not Mortality

Jason Kahn

January 16, 2014

News Daily News

La Anomalía en la Condución secundaria a la TAVR Empeora el Estado Funcional, No la Mortalidad

Jason Kahn

January 16, 2014

News Daily News

Post Angiography Testosterone Therapy Increases Cardiovascular Events in High-Risk Men

December 05, 2013

News Industry News

Volcano Announces Final Results of ADVISE II Registry, Prospectively Demonstrating Performance and Utility of iFR® Modality[1] to Measure and Document Severity of Intermediate Coronary Blockages

October 30, 2013

News Industry News

Boston Scientific Reports Favorable Clinical Trial Results Assessing The OffRoad™ Re-Entry Catheter System

October 11, 2013

News Industry News

FDA Advisory Panel Recommends Expanded Indication for Medtronic CRT Devices in Patients with AV Block and Reduced Heart Function

October 08, 2013

News Daily News

Meta-analysis: Women Fare Better Than Men After TAVR Despite More Complications

Yael L. Maxwell

September 27, 2013

News Daily News

Meta Análisis: A las Mujeres les Va Mejor que a los Hombres tras una TAVR a pesar de tener Más Complicaciones

Yael L. Maxwell

September 27, 2013

News Daily News

CADUCEUS: Autologous Stem Cells Safely Reverse Some MI Damage

September 27, 2013

News Daily News

NCDR Registries Give Nationwide Assessment of Cardiovascular Care

September 20, 2013

News Conference News ESC 2013

AQUARIUS: Aliskiren Fails Primary Endpoint But Surprises with MACE Reduction

Caitlin E. Cox

September 04, 2013

News Conference News ESC 2013

New Alternatives Match Efficacy to Warfarin in High-Risk Subgroups

Caitlin E. Cox

September 03, 2013

News Daily News

Bleeding Risk of Triple Therapy Not Attenuated by Well-Controlled Warfarin

August 30, 2013

Advertisement

Global SYMPLICITY Registry Still Shows Positive Results for Renal Denervation

High Sensitivity Troponin T Assay Shows Strong Prognostic Ability in STEMI Patients

CoreValve Reduces Mortality at 1 Year in Patients at Extreme Surgical Risk

CoreValve Reduce la Mortalidad al cabo de 1 Año en Pacientes de Riesgo Quirúrgico Extremo

Abbott Completes Enrollment of Absorb™ Randomized Clinical Trials in the United States, Japan and China

Una Prueba de Reactividad Coronaria Resulta Prometedora en Pacientes con Arterias No Obstruidas

Transcatheter Device Matches Surgery for Closure of Ventricular Septal Defects

TAVR-Linked Conduction Abnormality Worsens Functional Status, but Not Mortality

La Anomalía en la Condución secundaria a la TAVR Empeora el Estado Funcional, No la Mortalidad

Post Angiography Testosterone Therapy Increases Cardiovascular Events in High-Risk Men

Volcano Announces Final Results of ADVISE II Registry, Prospectively Demonstrating Performance and Utility of iFR® Modality[1] to Measure and Document Severity of Intermediate Coronary Blockages

Boston Scientific Reports Favorable Clinical Trial Results Assessing The OffRoad™ Re-Entry Catheter System

FDA Advisory Panel Recommends Expanded Indication for Medtronic CRT Devices in Patients with AV Block and Reduced Heart Function

Meta-analysis: Women Fare Better Than Men After TAVR Despite More Complications

Meta Análisis: A las Mujeres les Va Mejor que a los Hombres tras una TAVR a pesar de tener Más Complicaciones

CADUCEUS: Autologous Stem Cells Safely Reverse Some MI Damage

NCDR Registries Give Nationwide Assessment of Cardiovascular Care

AQUARIUS: Aliskiren Fails Primary Endpoint But Surprises with MACE Reduction

New Alternatives Match Efficacy to Warfarin in High-Risk Subgroups

Bleeding Risk of Triple Therapy Not Attenuated by Well-Controlled Warfarin

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content